Search research articles
Contact Us
Filters
Showing results (61-70 of 84) with videos related to
Page
of 9
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 14, 2020
The GABA<sub>B</sub> receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives
Francesca Ferlenghi, Paola Maccioni, Claudia Mugnaini, et al.
Endocrine Pathology
|
May 4, 2020
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
Marco Schiavo Lena, Stefano Partelli, Paola Castelli, et al.
Journal of Medicinal Chemistry
|
September 29, 2006
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists
Clementina Manera, Veronica Benetti, M Paola Castelli, et al.
BMC Psychiatry
|
May 11, 2006
Perceived quality of life in obsessive-compulsive disorder: related factors
Beatriz Rodriguez-Salgado, Helen Dolengevich-Segal, Manuel Arrojo-Romero, et al.
Psychopharmacology
|
July 3, 2007
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice
Marco Bortolato, Roberto Frau, Marco Orrù, et al.
Plos One
|
May 5, 2012
Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice
Maria Franca Marongiu, Daniela Poddie, Susanna Porcu, et al.
Pharmacology, Biochemistry, and Behavior
|
July 6, 2025
The novel synthesized naltrexone-related MOR antagonist AT-99 counteracts dopamine releasing and behavioral depressant morphine-induced effects
Rafaela Mostallino, Francesca Caria, Aurora Musa, et al.
Scientific Reports
|
December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
Mauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.
Neuropharmacology
|
December 22, 2015
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135
Maria Antonietta De Luca, M Paola Castelli, Barbara Loi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 19, 2014
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats
Miriam Melis, Claudia Sagheddu, Marta De Felice, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 84) with videos related to
Sort By:
Page
of 9
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 14, 2020
The GABA<sub>B</sub> receptor positive allosteric modulator COR659: In vitro metabolism, in vivo pharmacokinetics in rats, synthesis and pharmacological characterization of metabolically protected derivatives
Francesca Ferlenghi, Paola Maccioni, Claudia Mugnaini, et al.
Endocrine Pathology
|
May 4, 2020
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
Marco Schiavo Lena, Stefano Partelli, Paola Castelli, et al.
Journal of Medicinal Chemistry
|
September 29, 2006
Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists
Clementina Manera, Veronica Benetti, M Paola Castelli, et al.
BMC Psychiatry
|
May 11, 2006
Perceived quality of life in obsessive-compulsive disorder: related factors
Beatriz Rodriguez-Salgado, Helen Dolengevich-Segal, Manuel Arrojo-Romero, et al.
Psychopharmacology
|
July 3, 2007
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice
Marco Bortolato, Roberto Frau, Marco Orrù, et al.
Plos One
|
May 5, 2012
Reversible disruption of pre-pulse inhibition in hypomorphic-inducible and reversible CB1-/- mice
Maria Franca Marongiu, Daniela Poddie, Susanna Porcu, et al.
Pharmacology, Biochemistry, and Behavior
|
July 6, 2025
The novel synthesized naltrexone-related MOR antagonist AT-99 counteracts dopamine releasing and behavioral depressant morphine-induced effects
Rafaela Mostallino, Francesca Caria, Aurora Musa, et al.
Scientific Reports
|
December 11, 2019
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
Mauro Cives, Stefano Partelli, Raffaele Palmirotta, et al.
Neuropharmacology
|
December 22, 2015
Native CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135
Maria Antonietta De Luca, M Paola Castelli, Barbara Loi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
September 19, 2014
Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats
Miriam Melis, Claudia Sagheddu, Marta De Felice, et al.
Page
of 9